• Critical Innovations

Successful porcine safety trial of the F.O.A.M.™ device published in Military Medicine

Severe intra-abdominal bleeding currently requires operative treatment by trained surgeons, while Critical Innovations' patented F.O.A.M.™ technology task-shifts to allow earlier abdominal hemostasis by a wider range of providers. A recent article in Military Medicine evaluated the characteristics, survival, and histological analysis of using the F.O.A.M.™ device in a porcine model. In the study, F.O.A.M.™ reached the desired intra-abdominal pressure endpoint while not significantly altering basic hematologic parameters. These results provide strong support for the safety of the FOAM™ device and will support the design of further regulatory studies in swine and humans. See full article here.

6 views0 comments

Recent Posts

See All

Critical Innovations is happy to announce that it recently signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Chemical Biologica

Critical Innovations signed a new Cooperative Research and Development Agreement (CRADA) with the Naval Medical Center San Diego / Navy Medicine Readiness and Training Command San Diego. The company i